| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Department Molecular Genetics, Beijing Institute of Biotechnology, Beijing [J. J. H., Y. X. B., S. W. H., J. L., B. X., C-f. H.]; Institute of Molecular Biology and Open Lab of Chemical Biology of The Institute of Molecular Technology for Drug Discovery and Synthesis [J. J. H., M. C. L., H-f. K.]; and Department of Medicine, The University of Hong Kong, Pokfulam Hong Kong [D. D. J., B. C. Y. W.], China
The COOH-terminus of telomerase reverse transcriptase (hTERT) has been shown to participatein the nuclear translocation of TERT. Here, we constructed plasmids expressing the COOH-terminal Mr 27,000 polypeptide of hTERT (hTERTC27) withthe telomerase RNA-binding domains and the reverse transcriptase domains deleted. We showed that ectopic overexpression of this polypeptide caused a defect in telomere maintenance in hTERT-positive HeLa cells, which led to senescence-like growth arrest and apoptosis. The hTERTC27 appears to work by inducing telomere dysfunction, exemplified by significantly increased anaphase chromosome end-to-end fusion events in transfected cells. Significantly, it had no effect on the cellular telomerase enzymatic activity or telomere length. The in vivo effect was further demonstrated as HeLa cells stably expressing hTERTC27 have significantly lower growth rate and reduced tumorigenicity in nude mice xenografts. Results from this study revealed an important function for the COOH terminus of hTERT in maintaining the integrity of telomere structure and chromosome ends, as well as in cell senescence and apoptosis. Furthermore, hTERTC27 provides a new strategy for cancer therapy by inducing telomere dysfunction in cancer cells without affecting the telomerase enzymatic activity.
This article has been cited by other articles:
![]() |
J. Lin, R. Jin, B. Zhang, H. Chen, Y. X. Bai, P. X. Yang, S. W. Han, Y. H. Xie, P. T. Huang, C. Huang, et al. Nucleolar localization of TERT is unrelated to telomerase function in human cells J. Cell Sci., July 1, 2008; 121(13): 2169 - 2176. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Huard, T. J. Moriarty, and C. Autexier The C terminus of the human telomerase reverse transcriptase is a determinant of enzyme processivity Nucleic Acids Res., July 15, 2003; 31(14): 4059 - 4070. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Kosciolek, K. Kalantidis, M. Tabler, and P. T. Rowley Inhibition of Telomerase Activity in Human Cancer Cells by RNA Interference Mol. Cancer Ther., March 1, 2003; 2(3): 209 - 216. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |